 
September 8, 2008
Virginia School Gets $100 Million for Microbicide Research
The East Virginia Medical School’s Contraceptive Research and Development (CONRAD) program in Arlington was awarded $100 million, the largest grant in the school’s history, by the U.S. Agency for International Development to create a product that prevents the transmission of the virus that causes AIDS, reports The Virginia Pilot.
The grant will help CONRAD further its two-decade study of microbicide creams, topical gels and oral pills that would block not only HIV but also other sexually transmitted infections (STIs). One of the study’s benefits is that it may help women—who account for half the world’s HIV cases—become less reliant on their partners’ condom use and offer them an alternative prevention strategy that they can control.
According to the newspaper, the CONRAD researchers are also trying to develop preventative products that work over long periods of time as opposed to gels that are applied before sex.
Search: East Virginia Medical School, CONRAD, microbicide
Scroll down to comment on this story.
Previous Comments:
[Go to top]
|
